Dernièrement…

Welcome @AmoebaNature as a featured exhibitor at the BioSolutions Conference & Expo!

Amoéba is an innovative #greentech company providing the industry with disruptive & sustainable solutions for key resource treatment. Learn more at http://ow.ly/icPi50Mzv8N

#BioSolutions

📣 Communiqué de presse : https://bit.ly/3RbfQHe
#Amoéba annonce l’annulation de l’émission de la 8° tranche optionnelle d’OCA et la signature d’un contrat avec Redbridge Debt and Treasury Advisory afin d’adapter sa stratégie financière aux enjeux de transformation industrielle

📣 Communiqué de presse : https://bit.ly/3X2hdKt
#Amoéba confirme son éligibilité au dispositif PEA-PME. Les #actions AMOEBA peuvent donc être intégrées dans les portefeuilles PEA PME, dédiés aux #investissements dans les #PME et #ETI selon les critères réglementaires.

🎥 @Fabrice Plasson, PDG d’#Amoéba, revient sur cette année exceptionnelle dans une vidéo dédiée au #bilan 2022 et aux #perspectives 2023. AMM, nouvelle usine, stratégie, plan de financement, tant de sujets abordés sur la chaîne #YouTube d’#Amoéba : https://bit.ly/3Wz75bz

Ordinary and extraordinary general meeting to be held on 24 May 2022

Ordinary and extraordinary general meeting to be held on 24 May 2022 – Modalities through which the preparatory documents will be made available

The company’s shareholders are invited to attend the ordinary and extraordinary general
meeting which will be held on: Tuesday 24 may 2022 – 9 am at the company registered office – 38 Avenue des Frères Montgolfier- 69680 CHASSIEU.

The notice of the meeting as a notice of convocation, including the agenda and the planned
resolutions, was published in the BALO (Bulletin of obligatory legal announcements) of 18 april, 2022.
The documents stipulated by article R.225-83 of the French commercial code are available to
shareholders from the moment that the assembly is convened, in line with the applicable regulatory
requirements:
• Any registered shareholder can, until the fifth day (inclusive) before the assembly, ask the
company to send him these documents. For holders of bearer shares, this right can only be
exercised upon presentation of a statement of participation in the accounts of bearer shares
held by the authorised intermediary;
• Any shareholder can consult these documents at the company’s headquarters during the 15
days preceding the date of the meeting.

For information, electronic voting via the VOTACCESS secure voting platform for the General Meeting
of Tuesday, May 24, 2022 will be open from May 6, 2022 until Monday, May 23, 2022 at 3:00 pm (Paris
time). Shareholders wishing to use this platform can consult the access conditions in the notice of
meeting and on the company’s website (https://amoeba-nature.com/investisseur/assembleegenerale).

In the context of the coronavirus epidemic (COVID-19), the procedures for holding the Shareholders’
Meeting may change depending on health and/or legal requirements. Shareholders are invited to
regularly consult the section dedicated to the Shareholders’ Meeting on the Company’s website
(https://www.amoeba-nature.com/Investors/General-assembly).
The results of the votes on resolutions will be posted on the Company’s website.